ΑΡΧΙΚΗ > Πληροφορίες για την εταιρεία> Ιστορικό
6 Appointed ATC (Advanced Technology Center)
3 InBody sales and R&D cooperation with GE Healthcare
12 Awarded 5 million dollar export prize (from KITA)
10 Launched Biospace China Inc. in Shanghai
12 Awarded Korean World-class Product 2007 by Minister of Commerce, Industry and Energy
8 Awarded Certificate of INNO-BIZ by Small and Medium Business Administration
9 For Covenient use body composition analyzer, InBody230, released
4 Technology innovation enterprise awarded by Korea Institute of Science & Technology (KiSTEP)
4 High-precision body composition analyzers united under the InBody series brand Completely new product lineup introduced with the new release of the InBody720, InBody520, InBody330, and InBody220 high-precision body composition analyzers
1 Received FDA approval of newly added InBody elements
10 Bedside-type, high-precision body composition analyzer (InBody S20) released
10 Lower-priced body composition analyzer, FINA, released
7 Achieved ISO 9001 certification following its modification in 2000
3 High-precision body composition analyzer (InBody 4.0) released Achieved certification as a world first-class company Achieved InBody approval from the United States FDA
9 Data management system, Lookin’Body 2.0, for the InBody released Head office relocated to current address
3 Lower-priced body composition analyzer, Salus, released
11 Achieved CE certification for the Salus
2 High-precision body composition analyzer operation software (English language), Lookin’Body, released
12 Listed on the KOSDAQ
11 Awarded silver medal in the high-precision production technology part of the 30th High-Precision Technology Promotion Contest sponsored by the Small and Medium Business Administration
10 EU branch office (Germany) established
8 High-precision body composition analyzer operation software, Lookin’ Body, released
6 United States branch office established Japan branch office established
12 Achieved medical device clearance in Japan
11 Finalized technological transfer agreement with the Yamato Company in Japan
9 Achieved UL in the United States
7 Achieved the excellent industrial design mark (GD) Ultra-sound anthropometer released
6 High-precision body composition analyzer (InBody 3.0) released
5 Achieved ISO 9001, ISO 13485 certification, and CE (SGS) for the InBody 3.0 Achieved KFDA (InBody 3.0 )
1 Selected as the superior technological competitiveness company by the Small and Medium Business Administration
10 Received ISO 9002 product quality certification
9 Achieved the domestic new technology (KT) mark
6 Selected as a notable venture company by the Small and Medium Business Administration
5 Selected as promising advanced technology company by the Small and Medium Business Administration Awarded the IR52 Technological Excellence Award by the Ministry of Science and Technology
4 Selected as promising small or medium-sized company by the Korea Institute of Industrial Technology
11 Bioengineering research center established
8 Received investment funding of 450 million Korean Won from the Jangeun Venture Capital Group (currently, Kukmin Venture Capital Co., Ltd.) and the 3rd Jangeun Venture Investment Association
9 High-precision body composition analyzer (InBody 2.0) released
5 Biospace Co., Ltd. established